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Cancerisacomplexgeneticdiseaseasaresultofaccumulated
genomic alterations which serve as the driving force in
initiating tumor development and propelling tumor pro-
gression. Recent advances in molecular genomic technology
and the success of human genome project have empowered
investigators with new tools in analyzing cancer genome
and transcriptome in great details and have expedited
the discovery of new cancer-associated genes. Decoding
the genetic history present in tumor DNA, as well as
identiﬁcation and characterization of molecular changes
involving cancer-associated genes and the pathways they
controlled, has not only shed new light on the molecular
etiologyofcancer, butalso has promises forthe development
of new diagnostic markers and novel therapeutics. In this
special issue, the papers focus on recent ﬁndings of markers
identiﬁed in female reproductive cancers including breast,
ovarian, endometrial, and trophoblast tumors. The selected
papers are not an exhaustive representation of the area of
biomarkersinfemalereproductivecancers.Nonetheless,they
represent the rich and many-faceted knowledge that we have
the pleasure of sharing that with readers. We would like to
thank the authors for their excellent contributions to this
special issue and the reviewers’ insightful input to ensure the
quality of this special issue.
Of particularly interest are the two timely review articles
b yA .M .K a r s te ta l .a n dA .L .G r o s se ta l .f o c u s i n go n
the possible precursor lesions in the development of female
reproductive cancer. The tubal origin of “ovarian” cancer
has recently been in the research spot-light because of the
identiﬁcation of potential precursor lesions of ovarian can-
cer, termed “serous tubal intraepithelial carcinoma” in the
fallopian tubes. Both articles critically review the published
studies and provide unique perspectives of the impact and
signiﬁcance of this new hypothesis in the ﬁeld of cancer
research.
Reviewarticles focusing onbiomarkers includinggenetic
(K. M. Hirshﬁeld et al.), microRNA(H. M. Heneghan et al.),
and cytokine (F. Barbieri et al.) summarize recent advances
in biomarker discovery and the translational application.
Those articles will serve as the source for the investigators
who wish to pursue in evaluating new potential markers in
the female reproductive cancer research. They also present
the new challenges in biomarker discovery, validation, and
veriﬁcation.
In addition to the ﬁve review articles, there are several
exciting original research articles describing discovery and
validation of biomarkers in female reproductive cancers.
Those papers includethe studies of fatty acid synthase (S. M.
Uedaetal.),miR200c(D.R.Cochraneetal.),geneexpression
(S. Konstantinovsky et al.), and cytogenetic markers (F.
Micci et al.). The ﬁndings from those studies could serve
as biological foundation for future exploration of how those
markers contribute to disease progression. The biomarkers
identiﬁed in these studies could also serve as a road map
for development of novel diagnosis tools and new targeted
therapies. This issue also reports a synergistic eﬀect of Pten
loss and oncogenic Krasmutation on the endometrial cancer
development (I. H. Kim et al.) and the result provides
new insight into the pathogenesis of endometrial carcinoma.
Finally, K. L. Yap et al. applied molecular genetic markers to
demonstrate a lack of a Y-chromosomal complement in the
majority of gestational trophoblastic neoplasms, suggesting2 Journal of Oncology
that most trophoblastic tumors are derived from previous
molar gestations. Because the molecular characters in ges-
tational trophoblastic disease are understudied, this short
report should provide new insight into the pathogenesis of
this rare but highly interesting gynecological neoplasm.
In conclusion, this special issue is by no means an
attempt to be comprehensive in covering the ﬁeld of female
reproductive cancer, but it provides excellent reviews and
research articles that may be useful for readers in this ﬁeld.
We hope that this special issue will inspire investigators in
launchingnew research endeavorinthisﬁeldandaregrateful
for the opportunity to manage this special issue.
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